Overview
1q21.1 microduplication syndrome (also known as 1q21.1 duplication syndrome or chromosome 1q21.1 duplication syndrome) is a rare chromosomal disorder caused by a small duplication of genetic material on the long arm of chromosome 1 at position 21.1. This region contains several genes, and the extra copy of these genes is thought to disrupt normal development, though the exact mechanisms are not fully understood. The condition is characterized by variable expressivity and incomplete penetrance, meaning that individuals carrying the duplication may have a wide range of symptoms or, in some cases, no apparent clinical features at all. The syndrome primarily affects the neurological, musculoskeletal, and craniofacial systems. Key clinical features include mild to moderate intellectual disability, developmental delay (particularly speech and language delay), autism spectrum disorder, and other behavioral or psychiatric manifestations such as attention deficit hyperactivity disorder (ADHD) and anxiety. Macrocephaly (abnormally large head size) is a frequently reported feature. Some individuals may present with mild dysmorphic facial features, though these are often subtle and nonspecific. Congenital heart defects have been reported in a subset of patients. Hypotonia (reduced muscle tone) in infancy and joint hypermobility may also occur. Growth parameters can be variable, with some individuals showing tall stature. There is currently no cure or specific targeted therapy for 1q21.1 microduplication syndrome. Management is symptomatic and supportive, tailored to each individual's clinical presentation. This may include early intervention programs, speech and occupational therapy, behavioral therapy, special educational support, and appropriate management of any cardiac or other organ-specific anomalies. Psychiatric symptoms may be managed with standard pharmacological and behavioral approaches. Genetic counseling is recommended for affected individuals and their families, as the duplication may be inherited from a mildly affected or apparently unaffected parent.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for 1q21.1 microduplication syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for 1q21.1 microduplication syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to 1q21.1 microduplication syndrome.
Community
No community posts yet. Be the first to share your experience with 1q21.1 microduplication syndrome.
Start the conversation →Latest news about 1q21.1 microduplication syndrome
No recent news articles for 1q21.1 microduplication syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about 1q21.1 microduplication syndrome
What is 1q21.1 microduplication syndrome?
1q21.1 microduplication syndrome (also known as 1q21.1 duplication syndrome or chromosome 1q21.1 duplication syndrome) is a rare chromosomal disorder caused by a small duplication of genetic material on the long arm of chromosome 1 at position 21.1. This region contains several genes, and the extra copy of these genes is thought to disrupt normal development, though the exact mechanisms are not fully understood. The condition is characterized by variable expressivity and incomplete penetrance, meaning that individuals carrying the duplication may have a wide range of symptoms or, in some cases
How is 1q21.1 microduplication syndrome inherited?
1q21.1 microduplication syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat 1q21.1 microduplication syndrome?
2 specialists and care centers treating 1q21.1 microduplication syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.